• 1
    Meijers-Heijboer EJ, Verhoog LC, Brekelmans CTM, et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet. 2000; 355: 20152020.
  • 2
    Scheuer L, Kauff N, Robson M, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J.Clin.Oncol. 2002; 20: 12601268.
  • 3
    Vasen HFA, Haites NE, Evans DGR, et al. Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. Eur J Cancer. 1998; 34: 19221926.
  • 4
    Brekelmans CT, Seynaeve C, Bartels CC, et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J.Clin.Oncol. 2001; 19: 924930.
  • 5
    Kriege M, Brekelmans CTM, Klijn JGM. MRI screening for breast cancer in women with a familial or genetic predisposition. Imaging Decis. 2005; 9: 1118.
  • 6
    Robson M. Breast cancer surveillance in women with hereditary risk due to BRCA1 or BRCA2 mutations. Clin Breast Cancer. 2004; 5: 260268.
  • 7
    Kriege M, Brekelmans CT, Boetes C, et al. MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch national study (MRISC). Fam Cancer. 2001; 1: 163168.
  • 8
    Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004; 351: 427437.
  • 9
    Cole P, Morrison AS. Basic issues in population screening for cancer. J Nat .Cancer Inst. 1980; 64: 12631272.
  • 10
    Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 1989; 59: 954958.
  • 11
    Anderson TJ, Lamb J, Alexander F, et al. Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project. Lancet. 1986; 1: 519523.
  • 12
    Burnside ES, Sickles EA, Sohlich RE, Dee KE. Differential value of comparison with previous examinations in diagnostic versus screening mammography. AJR Am J Roentgenol. 2002; 179: 11731177.
  • 13
    Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology. 2000; 215: 267279.
  • 14
    Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst. 2001; 93: 10951102.
  • 15
    Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004; 292: 13171325.
  • 16
    Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet. 2005; 365: 17691778.
  • 17
    Claus EB, Risch NJ, Thompson WD. Autosomal dominant inheritance of early onset breast cancer. Cancer. 1994; 73: 643651.
  • 18
    Liberman L, Menell JH. Breast imaging reporting and data system (BI-RADS). Radiol Clin North Am. 2002; 40: 409430.
  • 19
    American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS) Atlas. 3rd ed. Reston, VA: American College of Radiology; 1998.
  • 20
    Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol. 2001; 19: 35243531.
  • 21
    De Koning HJ, Fracheboud J, Boer R, et al. Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB). Int J Cancer. 1995; 60: 777780.
  • 22
    Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. JAMA. 1996; 276: 3943.
  • 23
    Kerlikowske K, Smith-Bindman R, Abraham LA, et al. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up. Radiology. 2005; 234: 684692.
  • 24
    Boer R, de Koning H, van Oortmarssen G, Warmerdam P, van der MP. Stage distribution at first and repeat examinations in breast cancer screening. J Med Screen. 1999; 6: 132138.